BHVN FY 2025 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$745M

Net Income

-$739M

EPS (Diluted)

$-6.86

Cash Flow

Operating Cash Flow

-$609M

Free Cash Flow

-$610M

Stock-Based Comp.

$112M

Balance Sheet

Total Assets

$451M

Total Liabilities

$399M

Stockholders' Equity

$52M

Cash & Equivalents

$230M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$745M	-$885M	+15.8%
Net Income	-$739M	-$846M	+12.7%